MCL1 is phosphorylated in the PEST region and stabilized upon ERK activation in viable cells, and at additional sites with cytotoxic okadaic acid or taxol
The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Abstract
BCL2 family members are subject to regulation at multiple levels, providing checks on their ability to contribute to tumorigenesis. However, findings on post-translational BCL2 phosphorylation in different systems have been difficult to integrate. Another antiapoptotic family member, MCL1, exhibits a difference in electrophoretic mobility upon phosphorylation induced by an activator of PKC (12-O-tetradecanoylphorbol 13-acetate; TPA) versus agents that act on microtubules or protein phosphatases 1/2A. A multiple pathway model is now presented, which demonstrates that MCL1 can undergo distinct phosphorylation events - mediated through separate signaling processes and involving different target sites - in cells that remain viable in the presence of TPA versus cells destined to die upon exposure to taxol or okadaic acid. Specifically, TPA induces phosphorylation at a conserved extracellular signal-regulated kinase (ERK) site in the PEST region (Thr 163) and slows turnover of the normally rapidly degraded MCL1 protein; however, okadaic acid and taxol induce ERK-independent MCL1 phosphorylation at additional discrete sites. These findings add a new dimension to our understanding of the complex regulation of antiapoptotic BCL2 family members by demonstrating that, in addition to transcriptional and post-transcriptional regulation, MCL1 is subject to multiple, separate, post-translational phosphorylation events, produced in living versus dying cells at ERK-inducible versus ERK-indepe…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“MCL-1 phosphorylation at T163 decreased acutely upon trametinib treatment consistent with a loss of ERK phosphorylation59 and then rebounded at later time points coinciding with activation of JNK (Fig. S11A).”
From LKB1 regulates JNK-dependent stress signaling and apoptotic dependency of KRAS-mutant lung cancers (2025) · cites this paper as [59]
In the citing paper
“ERK1/2 stabilise MCL1 through phosphorylation of T163 and indirectly through RSK-mediated inhibition of GSK39.”
From Targeting melanoma’s MCL1 bias unleashes the apoptotic potential of BRAF and ERK1/2 pathway inhibitors (2019) · cites this paper as [9]
In the citing paper
“ERK-mediated phosphorylation of the MCL-1-PEST domain has been reported to limit MCL-1 degradation.”
From BCL-XL inhibition induces an FGFR4-mediated rescue response in colorectal cancer (2022) · cites this paper as Domina et al., 2004
In the citing paper
“Our data therefore suggest that the induction of MCL-1 protein upon A-1155463 treatment could be mediated by FGFR4-driven ERK signaling (Domina et al., 2004) (Figure 5C).”
From BCL-XL inhibition induces an FGFR4-mediated rescue response in colorectal cancer (2022) · cites this paper as Domina et al., 2004
Citations
Cites
Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability
Sears, R., Nuckolls, F., Haura, E., Taya, Y., Tamai, K., & Nevins, J. R. (2000) · Genes & Development · doi:10.1101/gad.836800 · Cited by 1,393 · cited 2×
“Since the degradation of a variety of other PEST proteins is affected by phosphorylation (Rechsteiner, 1990; Clurman et al., 1996; Chen et al., 2000; Gregory and Hann, 2000; Sears et al., 2000; Koepp et al., 2001), we wondered whether this might likewise be the case with MCL1.”
BackgroundCurrent Protocols in Protein Science
(2018) · Current Protocols in Protein Science · doi:10.1002/(issn)1934-3663 · Cited by 1,189
Ca 2+ -Induced Apoptosis Through Calcineurin Dephosphorylation of BAD
Wang, H.-G., Pathan, N., Ethell, I. M., Krajewski, S., Yamaguchi, Y., Shibasaki, F., McKeon, F., Bobo, T., Franke, T. F., & Reed, J. C. (1999) · Science · doi:10.1126/science.284.5412.339 · Cited by 1,132 · cited 2×
“This latter modification has been extensively characterized in the case of the proapoptotic family member BAD (Scheid et al., 1999; Wang et al., 1999; Harada et al., 2001).”
BackgroundTsujimoto, Y., & Croce, C. M. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.14.5214 · Cited by 1,106 · cited 1×
“Expression of such viability-regulating gene products is often aberrant in cancer, as exemplified by the BCL2 overexpression seen in follicular lymphoma (Tsujimoto and Croce, 1986).”
BackgroundYamamoto, K., Ichijo, H., & Korsmeyer, S. J. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.12.8469 · Cited by 1,003 · cited 4×
“Conversion of Ser 70 and/or Ser 87 to Ala similarly resulted in enhanced viability promotion in human Jurkat or mouse WEHI231 cells (Yamamoto et al., 1999).”
BackgroundMethodInfluentialMCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL2.
Kozopas, K. M., Yang, T., Buchan, H. L., Zhou, P., & Craig, R. W. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.8.3516 · Cited by 961 · cited 3×
“…and slows turnover of the MCL1 protein We focused first on further studies with TPA, since we have extensively examined the effects of this agent on MCL1 expression and phosphorylation (Kozopas et al., 1993; Yang et al., 1996; Zhou et al., 1997; Townsend et al., 1998, 1999; Domina et al., 2000).”
BackgroundSelf-citationGeneration of Destabilized Green Fluorescent Protein as a Transcription Reporter
Li, X., Zhao, X., Fang, Y., Jiang, X., Duong, T., Fan, C., Huang, C.-C., & Kain, S. R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.52.34970 · Cited by 846 · cited 2×
“MCL1 turnover was assessed using standard methods (Li et al., 1998; Akgul et al., 2000; Gregory and Hann, 2000; Cuconati et al., 2003), by exposing cells to cycloheximide to inhibit protein synthesis (25 mg/ml) and monitoring loss of the existing MCL1 protein over time by Western blotting.”
MethodDevelopment and maintenance of B and T lymphocytes requires antiapoptotic MCL-1
Opferman, J. T., Letai, A., Beard, C., Sorcinelli, M. D., Ong, C. C., & Korsmeyer, S. J. (2003) · Nature · doi:10.1038/nature02067 · Cited by 801 · cited 1×
“A distinctive characteristic of MCL1 in these systems, as in differentiating cells like ML-1 cells, is its ability to act in a rapid but often shortterm fashion, under conditions of changing cell phenotype (Craig, 2002; Opferman et al., 2003).”
BackgroundPhosphorylation-Dependent Ubiquitination of Cyclin E by the SCF Fbw7 Ubiquitin Ligase
Koepp, D. M., Schaefer, L. K., Ye, X., Keyomarsi, K., Chu, C., Harper, J. W., & Elledge, S. J. (2001) · Science · doi:10.1126/science.1065203 · Cited by 762 · cited 1×
“Since the degradation of a variety of other PEST proteins is affected by phosphorylation (Rechsteiner, 1990; Clurman et al., 1996; Chen et al., 2000; Gregory and Hann, 2000; Sears et al., 2000; Koepp et al., 2001), we wondered whether this might likewise be the case with MCL1.”
BackgroundElimination of Mcl-1 is required for the initiation of apoptosis following ultraviolet irradiation
Nijhawan, D., Fang, M., Traer, E., Zhong, Q., Gao, W., Du, F., & Wang, X. (2003) · Genes & Development · doi:10.1101/gad.1093903 · Cited by 591 · cited 1×
“Whatever the mechanism, the importance of MCL1 turnover in the control of cell viability has recently been brought to the fore by the demonstration that loss of MCL1 is an early step in apoptosis induced by DNA damage or by the viral E1A protein (Cuconati et al., 2003; Nijhawan et al., 2003).”
Background
Cited by
Items 301–342 of 342
Impact of San-mediated Signaling on Glioblastoma and Neuroblastoma Metabolism
Silva, M. R. (2018) · FIU - Digital Commons (Florida International University) · doi:10.25148/etd.fidc006885
Role of the Bcl-2 family of cell death regulators at the Endoplasmic Reticulum
Jabbour, L. (2020) · theses.fr (ABES) · doi:10.70675/5c461851zfd1bz4f8ez814fz8469a2b26a04 · Cited by 3
Grummisch, J. A. (2015) · Carleton University's Institutional Repository (MacOdrum Library, Carleton University) · doi:10.22215/etd/2015-11099
BAD Phosphorylation: A Novel Link between Apoptosis and Cancer
Polzien, L. (2011)
van der Zwet, J. C. G. (2022) · Utrecht University Repository (Utrecht University) · doi:10.33540/1098
Mao, S., Ling, Q., Pan, J., Li, F., Huang, S., Ye, W., Wei, W., Lin, X., Yu, Q., Wang, Y., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-255509/v1
Mao, S., Ling, Q., Pan, J., Li, F., Huang, S., Ye, W., Wei, W., Lin, X., Yu, Q., Wang, Y., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-255509/v2
de Pontes, C. A. (2021) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.42.2021.tde-16022022-121208
Data from EPOX Inhibits Angiogenesis by Degradation of Mcl-1 through ERK Inactivation
Sun, H., Tsai, A.-C., Pan, S., Ding, Q., Yamaguchi, H., Lin, C., Hung, M., & Teng, C. (2023) · doi:10.1158/1078-0432.c.6518593
Data from EPOX Inhibits Angiogenesis by Degradation of Mcl-1 through ERK Inactivation
Sun, H., Tsai, A.-C., Pan, S., Ding, Q., Yamaguchi, H., Lin, C., Hung, M., & Teng, C. (2023) · doi:10.1158/1078-0432.c.6518593.v1
Data from Mcl-1 Is Required for Melanoma Cell Resistance to Anoikis
Boisvert-Adamo, K., Longmate, W. M., Abel, E. V., & Aplin, A. E. (2023) · doi:10.1158/1541-7786.c.6542034
Data from Mcl-1 Is Required for Melanoma Cell Resistance to Anoikis
Boisvert-Adamo, K., Longmate, W. M., Abel, E. V., & Aplin, A. E. (2023) · doi:10.1158/1541-7786.c.6542034.v1
Nguyen, T. M. T. (2022) · theses.fr (ABES) · doi:10.70675/00fcdbf3z09f8z4e95zacf8za4527bded1b5 · Cited by 2
Deciphering the pro-apoptotic pathway induced by UNC5B dependence receptor.
Karam, N. (2024) · HAL
Mao, S., Ling, Q., Pan, J., Li, F., Huang, S., Ye, W., Wei, W., Lin, X., Qian, Y., Wang, Y., et al. (2021) · Figshare · doi:10.6084/m9.figshare.14516545
Boumela, I. (2012) · theses.fr (ABES) · doi:10.70675/3b9f9c67z4d46z4684zb580ze108c73f3b0b
Renault, T. T. (2010) · theses.fr (ABES) · doi:10.70675/21fc59dcz18e1z4490z8916zceb56eb3779c · Cited by 3
Rôle de la kinase Akt dans la chimiorésistance : Régulation de l’équilibre Apoptose-Sénescence
Vétillard, A. (2015) · theses.fr (ABES) · doi:10.70675/d0db61dazb197z42dczbb98z6f0276f570b6
Molecular basis of BCL2L10/Nrh oncogenic activity in breast cancer
Nougarède, A. (2016) · theses.fr (ABES) · doi:10.70675/67283ec1z7040z4d6eza688z407667ae770d
“Indeed, Mcl-1 PEST domain phosphorylation is closely tied with its cellular stability (Domina et al., 2004).”
Régulation de la stabilité de la protéine anti-apoptotique BCL2A1
Lionnard, L. (2018) · theses.fr (ABES) · doi:10.70675/1eec02ffz98dez4a56z98e2z389a2cd8558d
Louault, K. (2018) · theses.fr (ABES) · doi:10.70675/0aef1137z5689z4922z8455zdbe4b757612c
Bcl2L10 : polymorphisme, résistance oncogénique et conséquences thérapeutique dans le cancer du sein
Quang, D. M. (2021) · theses.fr (ABES) · doi:10.70675/86dd7fafzcb40z4cedz8eb7zbb41268cd809
Thomine, C. (2023) · theses.fr (ABES) · doi:10.70675/d1e538f7z6e75z441az8e0fza6253fc7ebf8
Faccio, S. C. (2023) · theses.fr (ABES) · doi:10.70675/ef801426z642cz499dz8a76z5619ab40fa83
CDK9 inhibitor A09-003 overcomes TRAIL resistance via dual Mcl-1 suppression in breast cancer cells
Sim, K. M., Hwang, S., Park, S., Kim, E., Oh, S. H., & Kim, I.-S. (2026) · Discover Oncology · doi:10.1007/s12672-026-04958-6
“We then examined phosphorylation at threonine 163 (Thr163), a conserved MAP (mitogen-activated protein) kinase site within the PEST domain that regulates Mcl-1 stability [24–25].”
Combinatorial Targeting of Avapritinib-Driven MAP Kinase Activation in High-Grade GliomaPreprint
Koschmann, C. J., Schwark, K., Wink, K., Cola, A. D., Miclea, M., Patel, T., Kong, S., Stanczak, A., Doherty, R., Pearson, A., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-9974885/v1
Makkawi, R., Halsey, C. M. R., Murthy, V., Manalo, E. C., Cros, H., Yi, X., Cartier, J. M., Chang, M., Flory, M. R., Guptell, K., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.09.30.755770
Matsuura, Y., Manabe, T., Ohkubo, T., Kanda, M., Iwayama, K., Kamiyama, N., Chuma, M., & Tasaki, Y. (2026) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b26-00348
BindingDB Entry 50016046: Development of Mcl-1 inhibitors for cancer therapy.
BindingDB (2023) · UC San Diego · doi:10.7270/q2b28081
Metadata
- Authors
- Domina, A. M., Vrana, J. A., Gregory, M. A., Hann, S. R., & Craig, R. W.
- Affiliations
- Dartmouth College (US)
- Vanderbilt University (US)
- Corresponding author
- Craig, Ruth W
- Venue
- Oncogene
- Published
- 2004-06-07
- Volume
- 23
- Issue
- 31
- Pages
- 5301-5315
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2041230280
- Cited by
- 327
- References
- 58
- Citations by year
- 2026: 7 · 2025: 8 · 2024: 6 · 2023: 15 · 2022: 13 · 2021: 24 · 2020: 10 · 2019: 16 · 2018: 9 · 2017: 15 · 2016: 14 · 2015: 16 · 2014: 29 · 2013: 26 · 2012: 25
- FWCI
- 3.68
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Hitchcock Foundation
- National Cancer Institute (R01-CA57359, R01CA057359)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Keywords
- Mcl-1, protein phosphorylation, ERK signaling, protein stabilization, Bcl-2 family proteins, anti-apoptotic proteins, okadaic acid, paclitaxel, microtubule stabilization, protein phosphatase 2A, phorbol myristate acetate, post-translational regulation, apoptosis
- MeSH terms
- Amino Acid Sequence, Animals, Antineoplastic Agents, Phytogenic, Binding Sites, Carcinogens, Cell Survival, Dogs, Dose-Response Relationship, Drug, Enzyme Activation, Enzyme Inhibitors, Cricetinae, Humans, Molecular Sequence Data, Neoplasm Proteins, Peptide Mapping, Phosphorylation, Precipitin Tests, Protein Kinase C, Tetradecanoylphorbol Acetate, Threonine, Time Factors, Transfection, Signal Transduction, CHO Cells, Apoptosis, Paclitaxel, Protein Structure, Tertiary, Proto-Oncogene Proteins c-bcl-2, Okadaic Acid, Mitogen-Activated Protein Kinases, MAP Kinase Signaling System, Cell Line, Tumor, Mice, Myeloid Cell Leukemia Sequence 1 Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.